Using Graphene-Based Biosensors to Detect Dopamine for Efficient Parkinson’s Disease Diagnostics

Abstract

Parkinson’s disease (PD) is a neurodegenerative disease in which the neurotransmitter dopamine (DA) depletes due to the progressive loss of nigrostriatal neurons. Therefore, DA measurement might be a useful diagnostic tool for targeting the early stages of PD, as well as helping to optimize DA replacement therapy. Moreover, DA sensing appears to be a useful analytical tool in complex biological systems in PD studies. To support the feasibility of this concept, this mini-review explores the currently developed graphene-based biosensors dedicated to DA detection. We discuss various graphene modifications designed for high-performance DA sensing electrodes alongside their analytical performances and interference studies, which we listed based on their limit of detection in biological samples. Moreover, graphene-based biosensors for optical DA detection are also presented herein. Regarding clinical relevance, we explored the development trends of graphene-based electrochemical sensing of DA as they relate to point-of-care testing suitable for the site-of-location diagnostics needed for personalized PD management. In this field, the biosensors are developed into smartphone-connected systems for intelligent disease management. However, we highlighted that the focus should be on the clinical utility rather than analytical and technical performance.

Artificial Intelligence (AI) and Internet of Medical Things (IoMT) Assisted Biomedical Systems for Intelligent Healthcare

“…Carbon-based nanomaterials such as carbon nanotubes and graphene conserve intrinsic electrical properties and excellent biocompatible properties required for bio-signal monitoring. These materials allow for integration with skin-compatible devices to create wearable monitoring devices [ 68 ]. Graphene is one of the most widely studied 2D nanomaterials adopted for biomedical research due to its enhanced stability, electronic mobility, and electrical conductivity.…”

CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease

“…Additionally, the symptomatic therapeutic modalities used have many side effects. With the progression of the disease, the nonlinear pharmacodynamics of dopamine (DA) replacement therapy complicates the optimization of a treatment regimen [69]. A few cell replacement therapy researchers have demonstrated the feasibility of producing DNs from human embryonic stem cells (hESCs) and implanting these cells in animal PD models [70,71].…”

Fluorescent Biosensors for the Detection of Viruses Using Graphene and Two-Dimensional Carbon Nanomaterials

“…Researchers are looking at new smartphone-connected POCT devices to improve data sensitivity, with additional advantages such as privacy and theft protection, medical recommendations, and time- and cost-intensive laboratory processing without sample pretreatment. They should be portable and user-friendly while still delivering appropriate analytical results and clinical relevance [ 102 ]. The sensitivity, low detection limit, and selectivity of the point-of-care (POC) devices must be improved by utilizing a sensing prototype based on a smart optoelectronic nanosystems, using precise diagnostics without interferents or loss to choose a real sample source.…”